Hemolens Diagnostics Spółka z o.o. (formerly LifeFlow Sp. z o.o.)
is implementing a project co-financed from the European Funds titled
“HEMOFLOW cloud-based platform for non-invasive hemodynamic diagnostics.”
The project aims at developing a cloud-based technology platform HEMOFLOW for non-invasive diagnostics of coronary artery disease that combines anatomical and functional evaluation of coronary blood flow correlated with myocardial perfusion assessment.
The HEMOFLOW PLATFORM will become a unique tool for CAD diagnostics, delivering solutions based on computer modelling and computational fluid mechanics to allow physicians to generate an independent structural and functional evaluation with the use of a virtual 3D coronary artery model (virtual measurement of fractional flow reserve, FFR) coupled with a 3D visualization of the myocardium (virtual 3D perfusion maps).
Project value: PLN 19,417,540.50
Co-funding from European Funds: PLN 12,953,985.55
Between November 1, 2016 and December 31, 2018, Hemolens Diagnostics Spółka z o.o. (formerly LifeFlow Sp. z o.o.) carried out a project co-financed from European Funds.
The R&D project titled ”LifeFlow” was implemented under Support (Grant) Agreement No. 2018/LSI/03/03 made on March 29, 2018 as part of Grant Project No. POIR.01.03.01-00-0032/16 carried out by Life Science Innovations Sp. z o. o. SK.
The aim of the project was product/technology development, including developing proprietary FFR-CT technology with parameters guaranteeing a continuous competitive advantage, obtaining certification and marketing authorization on selected markets, as well as the implementation of an intellectual property protection and management strategy.
Project value: PLN 3,000,000.00
Co-funding from European Funds: PLN 2,400,000.00